Oncological

Focused ultrasound offers the potential to treat many cancers through non-invasively destroying malignant tissue or enhancing adjuvant therapy (e.g. chemotherapy or radiation).

The technology is approved in Europe and the U.S. to relieve the pain in patients with bone metastases. In addition, focused ultrasound systems to treat prostate cancer are approved in Europe and are currently under FDA review and may be commercially available in the U.S. soon.

four pillars module newFocused ultrasound is also approved in Europe to treat patients with breast, liver, pancreatic and kidney cancers and soft tissue tumors.

U.S. studies using focused ultrasound to non-invasively destroy tumors in the breast, thyroid, and prostate are expected to begin soon. 

In pediatric oncology, definitive studies in children are likely to be delayed until more studies in adults have been completed and analysed. However, a new clinical trial at Children's National Medical Center in Washington, DC is focused on patients (less than 30 years of age) with recurrent solid tumors for which there are no curative treatments. 

In addition, there is significant research activity around the globe assessing the potential of the technology to enhance the delivery and effectiveness of cancer drugs. 

Learn more about focused ultrasound for: 

clinical stages key
Bladder Cancer Early Stage icon    
Bone Cancer Clinical Trials icon    
Bone Metastases FDA Approved icon Outside Approval icon Clinical Trials icon
Brain Tumors, Glioma and Metastatic Clinical Trials icon    
Breast Cancer Outside Approval icon Clinical Trials icon  
Cervical Cancer Early Stage icon    
Colorectal Cancer Clinical Trials icon    
Esophageal Cancer Early Stage icon    
Head and Neck Cancer Clinical Trials icon    
Kidney Cancer Outside Approval icon Clinical Trials icon  
Liver Cancer Outside Approval icon    
Lung Cancer Early Stage icon    
Neuroblastoma Early Stage icon    
Ovarian Cancer Early Stage icon    
Pancreatic Cancer Outside Approval icon Clinical Trials icon  
Prostate Cancer FDA Approved icon Outside Approval icon Clinical Trials icon
Sacral Chordomas Clinical Trials icon    
Soft Tissue Cancer Outside Approval icon Clinical Trials icon  

In this section

Treatment Sites

Clinical Trials